General Investing >> Money Manager Interviews >> February 19, 2001

Alidad Mireskandari – Monument Funds Group Inc

ALIDAD MIRESKANDARI, PhD is currently the Portfolio Manager of the Monument Medical Sciences Fund and is managing investments across all sectors of the Life Sciences Industry under the direction of Bob Grandhi, Monument Advisor's Chief Investment Officer. Before joining the firm, he was a Manager in the Life Sciences Industry Group at Pittiglio Rabin Todd & McGrath, a premier global consulting firm to high technology companies. Dr. Mireskandari consulted on development of technology and product cycle-time improvements in the pharmaceutical and medical devices industry. Earlier, he evaluated strategic business opportunities in the combinatorial chemistry industry for Fisher Scientifics' chemical division. For the five years prior to joining Fisher, Dr. Mireskandari was a Research Fellow at NIH's National Cancer Institute. In its Laboratory of Molecular Virology, he led a team conducting analysis of Human T-cell Leukemia Virus Type-1 (HTLV-1) infection and replication mechanisms. He earned a BS degree is Biology and a PhD in Genetics from GWU and an MBA in Finance from the University of Michigan Business School. Profile
TWST: Tell us something about the mandate of the Monument Medical

Sciences Fund. What kinds of companies are you able to invest in?

Dr. Mireskandari: We cover companies that provide healthcare